Airsupra 90-80 MCG inhaler 10.7GM
Ended Awarded Last action
- Contract number
- SPE2DR26F7VQ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,877
Award facts
- Contract value 100% obligated
- $18,876.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price delivery order has a ceiling value of $18.9K and an ultimate completion date of February 5, 2026. The contract was awarded on a competitive, non-set-aside basis and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veteran healthcare programs.
This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The contractor's receipt of this award demonstrates its capability to fulfill federal medical supply requirements through open competition and reflects its significant role in the Defense Health Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7VQ0?
SPE2DR26F7VQ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F7VQ0 worth?
The government has obligated $18,877 on SPE2DR26F7VQ0.
Is contract SPE2DR26F7VQ0 an order under another contract?
Yes. SPE2DR26F7VQ0 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VQ0 competed?
The extent of competition for SPE2DR26F7VQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award